NCT02029352View on ClinicalTrials.gov

Topical Green Tea Ointment in Treatment of Superficial Skin Cancer

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

September 30, 2015

Study Completion Date

February 29, 2016

Conditions
Carcinoma, Basal Cell
Interventions
DRUG

Sinecatechins 10%

DRUG

Placebo

Composition, apart from the active substance, is otherwise identical to the investigational medical product.

Trial Locations (1)

6202 AZ

Maastricht University Medical Centre, Maastricht

Sponsors

Collaborators (1)

Medigene AG
All Listed Sponsors
collaborator

Will-Pharma

UNKNOWN

collaborator

Medigene AG

INDUSTRY

lead

Maastricht University Medical Center

OTHER